Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Zhejiang Shenghua Biok Biology Co., Ltd. is a leading Chinese biotechnology company specializing in the production of veterinary pharmaceuticals, agrochemicals, and feed additives through advanced fermentation processes. Established in 1993 and headquartered in Deqing, Zhejiang, the company has become one of the world's largest manufacturers of abamectin and ivermectin. Its extensive product portfolio also includes key animal health products such as colistin sulfate, maduramicin, and salinomycin. The company operates as a core subsidiary of Zhejiang Hanye Co., Ltd. and maintains a strong global presence, exporting to markets in Southeast Asia, Europe, and the Americas. Shenghua Biok is recognized for its large-scale manufacturing capabilities and adherence to international quality standards.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Zhejiang Shenghua B.B..